CSO Dr. Eva Prieschl-Grassauer is talking about the low solubility of hydrophobic active ingredients, the associated problems of bioavailability and efficacy, and new solutions for drug development. Read the full article here (p. 58):
CSO Dr. Eva Prieschl-Grassauer is talking about the low solubility of hydrophobic active ingredients, the associated problems of bioavailability and efficacy, and new solutions for drug development. Read the full article here (p. 58):